2x20 Gbps - 40 GHz OFDM Ro-FSO transmission with mode division multiplexing

Radio-over-Free-Space-Optics (Ro-FSO) is a promising technology for future wireless networks.In this work, we have designed a hybrid orthogonal frequency division multiplexing (OFDM) Ro-FSO system for transmission of two independent channels by mode division multiplexing.Two independent 40 GHz radio signals are optically modulated at 20Gbps by mode division multiplexing of two laser modes LG00 and LG10 and transmitted over a free-space link of 20 km to 100 km. The performance of proposed Ro-FSO system is also evaluated under the effect of strong atmospheric turbulences

Application of the Spiritual Intelligence Self-Report Inventory (SISRI-24) Among Hong Kong University Students

The aim of this study was to examine the psychometric properties of the Chinese version of the Spiritual Intelligence Self-Report Inventory (SISRI-24). Two hundred thirteen undergraduate students in Hong Kong completed the Chinese SISRI-24, the Meaning of Life Questionnaire, the Metapersonal Self-Construal Scale, and the Satisfaction with Life Scale to allow examination of internal reliability and construct validity. Confirmatory factor analysis was also performed to examine whether the model of King and DeCicco (2009) fit our data. Our results indicated that the full scale of the Chinese SISRI-24 and its four subscales had acceptable internal reliability. The results also showed a positive relationship between spiritual intelligence and metapersonal self-construal. However, no significant relationship was reported between spiritual intelligence and life satisfaction. As such, construct validity was low to moderate. This study can be considered a foundation for understanding and measuring spiritual intelligence among undergraduate students in Hong Kong. Future research directions are suggested

1H-NMR urinary metabolomic profiling for diagnosis of gastric cancer

Background: Metabolomics has shown promise in gastric cancer (GC) detection. This research sought to identify whether GC has a unique urinary metabolomic profile compared with benign gastric disease (BN) and healthy (HE) patients. Methods: Urine from 43 GC, 40 BN, and 40 matched HE patients was analysed using 1H nuclear magnetic resonance (1H-NMR) spectroscopy, generating 77 reproducible metabolites (QC-RSD Results: GC displayed a clear discriminatory biomarker profile; the BN profile overlapped with GC and HE. LASSO-LR identified three discriminatory metabolites: 2-hydroxyisobutyrate, 3-indoxylsulfate, and alanine, which produced a discriminatory model with an area under the ROC of 0.95. Conclusions: GC patients have a distinct urinary metabolite profile. This study shows clinical potential for metabolic profiling for early GC diagnosis

SUBSEA 2019 Expedition to the Gorda Ridge

The SUBSEA (Systematic Underwater Biogeochemical Science and Exploration Analog) program blends ocean exploration with “ocean worlds” research, along with NASA analog and work studies research, to address science, science operations, and technology knowledge gaps related to the exploration of our solar system. The science group researches venting fluids at isolated seamounts and spreading ridges in the Pacific Ocean as analog environments to putative volcanically hosted hydrothermal systems on other “ocean worlds” (defined as places in the outer solar system that could possess subsurface oceans). The science operations research group studies E/V Nautilus architecture, distributed teams, communication, and lowlatency telerobotics. The technology research group provided Exploration Ground Data Systems (xGDS) software to the shore team to support the integration and visualization of diverse data products during the cruise

The effect of stellar evolution on SiC dust grain sizes

Stars on the asymptotic giant branch (AGB) produce dust in their circumstellar shells. The nature of the dust-forming environment is influenced by the evolution of the stars, in terms of both chemistry and density, leading to an evolution in the nature of the dust that is produced. Carbon-rich AGB stars are known to produce silicon carbide (SiC). Furthermore, observations of the ~11um SiC feature show that the spectral features change in a sequence that correlates with stellar evolution. We present new infrared spectra of amorphous SiC and show that the ~9um feature seen in both emission and absorption, and correlated with trends in the ~11um feature, may be due to either amorphous SiC or to nano-crystalline diamond with a high proportion of Si substituting for C. Furthermore, we identify SiC absorption in three ISO spectra of extreme carbon stars, in addition to the four presented by Speck et al. (1997). An accurate description of the sequence in the IR spectra of carbon stars requires accounting for both SiC emission and absorption features. This level of detail is needed to infer the role of dust in evolution of carbon stars. Previous attempts to find a sequence in the infrared spectra of carbon stars considered SiC emission features, while neglecting SiC absorption features, leading to an interpretation of the sequence inadequately describes the role of dust. We show that the evolutionary sequence in carbon star spectra is consistent with a grain size evolution, such that dust grains get progressively smaller as the star evolves. The evolution of the grain sizes provides a natural explanation for the shift of the ~11um SiC feature in emission and in absorption. Further evidence for this scenario is seen in both post-AGB star spectra and in meteoritic studies of presolar grains.Comment: accepted by ApJ 8 figure

Assessment of F/HN-Pseudotyped Lentivirus as a Clinically Relevant Vector for Lung Gene Therapy

RATIONALE: Ongoing efforts to improve pulmonary gene transfer thereby enabling gene therapy for the treatment of lung diseases, such as cystic fibrosis (CF), has led to the assessment of a lentiviral vector (simian immunodeficiency virus [SIV]) pseudotyped with the Sendai virus envelope proteins F and HN. OBJECTIVES: To place this vector onto a translational pathway to the clinic by addressing some key milestones that have to be achieved. METHODS: F/HN-SIV transduction efficiency, duration of expression, and toxicity were assessed in mice. In addition, F/HN-SIV was assessed in differentiated human air-liquid interface cultures, primary human nasal epithelial cells, and human and sheep lung slices. MEASUREMENTS AND MAIN RESULTS: A single dose produces lung expression for the lifetime of the mouse (~2 yr). Only brief contact time is needed to achieve transduction. Repeated daily administration leads to a dose-related increase in gene expression. Repeated monthly administration to mouse lower airways is feasible without loss of gene expression. There is no evidence of chronic toxicity during a 2-year study period. F/HN-SIV leads to persistent gene expression in human differentiated airway cultures and human lung slices and transduces freshly obtained primary human airway epithelial cells. CONCLUSIONS: The data support F/HN-pseudotyped SIV as a promising vector for pulmonary gene therapy for several diseases including CF. We are now undertaking the necessary refinements to progress this vector into clinical trials

Combinations of β-lactam or aminoglycoside antibiotics with plectasin are synergistic against methicillin-sensitive and methicillin-resistant Staphylococcus aureus.

Bacterial infections remain the leading killer worldwide which is worsened by the continuous emergence of antibiotic resistance. In particular, methicillin-sensitive (MSSA) and methicillin-resistant Staphylococcus aureus (MRSA) are prevalent and the latter can be difficult to treat. The traditional strategy of novel therapeutic drug development inevitably leads to emergence of resistant strains, rendering the new drugs ineffective. Therefore, rejuvenating the therapeutic potentials of existing antibiotics offers an attractive novel strategy. Plectasin, a defensin antimicrobial peptide, potentiates the activities of other antibiotics such as β-lactams, aminoglycosides and glycopeptides against MSSA and MRSA. We performed in vitro and in vivo investigations to test against genetically diverse clinical isolates of MSSA (n = 101) and MRSA (n = 115). Minimum inhibitory concentrations (MIC) were determined by the broth microdilution method. The effects of combining plectasin with β-lactams, aminoglycosides and glycopeptides were examined using the chequerboard method and time kill curves. A murine neutropenic thigh model and a murine peritoneal infection model were used to test the effect of combination in vivo. Determined by factional inhibitory concentration index (FICI), plectasin in combination with aminoglycosides (gentamicin, neomycin or amikacin) displayed synergistic effects in 76-78% of MSSA and MRSA. A similar synergistic response was observed when plectasin was combined with β-lactams (penicillin, amoxicillin or flucloxacillin) in 87-89% of MSSA and MRSA. Interestingly, no such interaction was observed when plectasin was paired with vancomycin. Time kill analysis also demonstrated significant synergistic activities when plectasin was combined with amoxicillin, gentamicin or neomycin. In the murine models, plectasin at doses as low as 8 mg/kg augmented the activities of amoxicillin and gentamicin in successful treatment of MSSA and MRSA infections. We demonstrated that plectasin strongly rejuvenates the therapeutic potencies of existing antibiotics in vitro and in vivo. This is a novel strategy that can have major clinical implications in our fight against bacterial infections

Emergence of Oseltamivir-Resistant Pandemic (H1N1) 2009 Virus within 48 Hours

An oseltamivir-resistant influenza A pandemic (H1N1) 2009 virus evolved and emerged from zero to 52% of detectable virus within 48 hours of a patient’s exposure to oseltamivir. Phylogenetic analysis and data gathered by pyrosequencing and cloning directly on clinical samples suggest that the mutant emerged de novo

Hematopoietic Cell Transplantation in Patients With Primary Immune Regulatory Disorders (PIRD): A Primary Immune Deficiency Treatment Consortium (PIDTC) Survey.

Primary Immune Regulatory Disorders (PIRD) are an expanding group of diseases caused by gene defects in several different immune pathways, such as regulatory T cell function. Patients with PIRD develop clinical manifestations associated with diminished and exaggerated immune responses. Management of these patients is complicated; oftentimes immunosuppressive therapies are insufficient, and patients may require hematopoietic cell transplant (HCT) for treatment. Analysis of HCT data in PIRD patients have previously focused on a single gene defect. This study surveyed transplanted patients with a phenotypic clinical picture consistent with PIRD treated in 33 Primary Immune Deficiency Treatment Consortium centers and European centers. Our data showed that PIRD patients often had immunodeficient and autoimmune features affecting multiple organ systems. Transplantation resulted in resolution of disease manifestations in more than half of the patients with an overall 5-years survival of 67%. This study, the first to encompass disorders across the PIRD spectrum, highlights the need for further research in PIRD management

FXR activation protects against NAFLD via bile-acid-dependent reductions in lipid absorption

FXR agonists are used to treat non-alcoholic fatty liver disease (NAFLD), in part because they reduce hepatic lipids. Here, we show that FXR activation with the FXR agonist GSK2324 controls hepatic lipids via reduced absorption and selective decreases in fatty acid synthesis. Using comprehensive lipidomic analyses, we show that FXR activation in mice or humans specifically reduces hepatic levels of mono- and polyunsaturated fatty acids (MUFA and PUFA). Decreases in MUFA are due to FXR-dependent repression of Scd1, Dgat2, and Lpin1 expression, which is independent of SHP and SREBP1c. FXR-dependent decreases in PUFAs are mediated by decreases in lipid absorption. Replenishing bile acids in the diet prevented decreased lipid absorption in GSK2324-treated mice, suggesting that FXR reduces absorption via decreased bile acids. We used tissue-specific FXR KO mice to show that hepatic FXR controls lipogenic genes, whereas intestinal FXR controls lipid absorption. Together, our studies establish two distinct pathways by which FXR regulates hepatic lipids